Christopher B Rodell1, Madonna E Lee1, Hua Wang1, Satoshi Takebayashi1, Tetsushi Takayama1, Tomonori Kawamura1, Jeffrey S Arkles1, Neville N Dusaj1, Shauna M Dorsey1, Walter R T Witschey1, James J Pilla1, Joseph H Gorman1, Jonathan F Wenk1, Jason A Burdick2, Robert C Gorman2. 1. From the Department of Bioengineering (C.B.R., N.N.D., S.M.D., J.A.B.), Gorman Cardiovascular Research Group, Department of Surgery (M.E.L., S.T., T.T., T.K., J.S.A., J.H.G., R.C.G.), and Department of Radiology (W.R.T.W., J.J.P.), University of Pennsylvania, Philadelphia; and Department of Mechanical Engineering (H.W., J.F.W.) and Department of Surgery (J.F.W.), University of Kentucky, Lexington. 2. From the Department of Bioengineering (C.B.R., N.N.D., S.M.D., J.A.B.), Gorman Cardiovascular Research Group, Department of Surgery (M.E.L., S.T., T.T., T.K., J.S.A., J.H.G., R.C.G.), and Department of Radiology (W.R.T.W., J.J.P.), University of Pennsylvania, Philadelphia; and Department of Mechanical Engineering (H.W., J.F.W.) and Department of Surgery (J.F.W.), University of Kentucky, Lexington. burdick2@seas.upenn.edu Robert.Gorman@uphs.upenn.edu.
Abstract
BACKGROUND: Injectable, acellular biomaterials hold promise to limit left ventricular remodeling and heart failure precipitated by infarction through bulking or stiffening the infarct region. A material with tunable properties (eg, mechanics, degradation) that can be delivered percutaneously has not yet been demonstrated. Catheter-deliverable soft hydrogels with in vivo stiffening to enhance therapeutic efficacy achieve these requirements. METHODS AND RESULTS: We developed a hyaluronic acid hydrogel that uses a tandem crosslinking approach, where the first crosslinking (guest-host) enabled injection and localized retention of a soft (<1 kPa) hydrogel. A second crosslinking reaction (dual-crosslinking) stiffened the hydrogel (41.4±4.3 kPa) after injection. Posterolateral infarcts were investigated in an ovine model (n≥6 per group), with injection of saline (myocardial infarction control), guest-host hydrogels, or dual-crosslinking hydrogels. Computational (day 1), histological (1 day, 8 weeks), morphological, and functional (0, 2, and 8 weeks) outcomes were evaluated. Finite-element modeling projected myofiber stress reduction (>50%; P<0.001) with dual-crosslinking but not guest-host injection. Remodeling, assessed by infarct thickness and left ventricular volume, was mitigated by hydrogel treatment. Ejection fraction was improved, relative to myocardial infarction at 8 weeks, with dual-crosslinking (37% improvement; P=0.014) and guest-host (15% improvement; P=0.058) treatments. Percutaneous delivery via endocardial injection was investigated with fluoroscopic and echocardiographic guidance, with delivery visualized by magnetic resonance imaging. CONCLUSIONS: A percutaneous delivered hydrogel system was developed, and hydrogels with increased stiffness were found to be most effective in ameliorating left ventricular remodeling and preserving function. Ultimately, engineered systems such as these have the potential to provide effective clinical options to limit remodeling in patients after infarction.
BACKGROUND: Injectable, acellular biomaterials hold promise to limit left ventricular remodeling and heart failure precipitated by infarction through bulking or stiffening the infarct region. A material with tunable properties (eg, mechanics, degradation) that can be delivered percutaneously has not yet been demonstrated. Catheter-deliverable soft hydrogels with in vivo stiffening to enhance therapeutic efficacy achieve these requirements. METHODS AND RESULTS: We developed a hyaluronic acid hydrogel that uses a tandem crosslinking approach, where the first crosslinking (guest-host) enabled injection and localized retention of a soft (<1 kPa) hydrogel. A second crosslinking reaction (dual-crosslinking) stiffened the hydrogel (41.4±4.3 kPa) after injection. Posterolateral infarcts were investigated in an ovine model (n≥6 per group), with injection of saline (myocardial infarction control), guest-host hydrogels, or dual-crosslinking hydrogels. Computational (day 1), histological (1 day, 8 weeks), morphological, and functional (0, 2, and 8 weeks) outcomes were evaluated. Finite-element modeling projected myofiber stress reduction (>50%; P<0.001) with dual-crosslinking but not guest-host injection. Remodeling, assessed by infarct thickness and left ventricular volume, was mitigated by hydrogel treatment. Ejection fraction was improved, relative to myocardial infarction at 8 weeks, with dual-crosslinking (37% improvement; P=0.014) and guest-host (15% improvement; P=0.058) treatments. Percutaneous delivery via endocardial injection was investigated with fluoroscopic and echocardiographic guidance, with delivery visualized by magnetic resonance imaging. CONCLUSIONS: A percutaneous delivered hydrogel system was developed, and hydrogels with increased stiffness were found to be most effective in ameliorating left ventricular remodeling and preserving function. Ultimately, engineered systems such as these have the potential to provide effective clinical options to limit remodeling in patients after infarction.
Authors: Samuel T Wall; Joseph C Walker; Kevin E Healy; Mark B Ratcliffe; Julius M Guccione Journal: Circulation Date: 2006-11-27 Impact factor: 29.690
Authors: Jennifer M Singelyn; Priya Sundaramurthy; Todd D Johnson; Pamela J Schup-Magoffin; Diane P Hu; Denver M Faulk; Jean Wang; Kristine M Mayle; Kendra Bartels; Michael Salvatore; Adam M Kinsey; Anthony N Demaria; Nabil Dib; Karen L Christman Journal: J Am Coll Cardiol Date: 2012-02-21 Impact factor: 24.094
Authors: J H Gorman; R C Gorman; T Plappert; B M Jackson; Y Hiramatsu; M G St John-Sutton; L H Edmunds Journal: J Thorac Cardiovasc Surg Date: 1998-03 Impact factor: 5.209
Authors: Sonya B Seif-Naraghi; Jennifer M Singelyn; Michael A Salvatore; Kent G Osborn; Jean J Wang; Unatti Sampat; Oi Ling Kwan; G Monet Strachan; Jonathan Wong; Pamela J Schup-Magoffin; Rebecca L Braden; Kendra Bartels; Jessica A DeQuach; Mark Preul; Adam M Kinsey; Anthony N DeMaria; Nabil Dib; Karen L Christman Journal: Sci Transl Med Date: 2013-02-20 Impact factor: 17.956
Authors: Elena Tous Kichula; Hua Wang; Shauna M Dorsey; Spencer E Szczesny; Dawn M Elliott; Jason A Burdick; Jonathan F Wenk Journal: Ann Biomed Eng Date: 2013-11-23 Impact factor: 3.934
Authors: Jingjie Hu; Hassan Albadawi; Brian W Chong; Amy R Deipolyi; Rahul A Sheth; Ali Khademhosseini; Rahmi Oklu Journal: Adv Mater Date: 2019-06-06 Impact factor: 30.849
Authors: Kevin L Sack; Eric Aliotta; Jenny S Choy; Daniel B Ennis; Neil H Davies; Thomas Franz; Ghassan S Kassab; Julius M Guccione Journal: Acta Biomater Date: 2020-05-16 Impact factor: 8.947
Authors: Leo L Wang; Jennifer J Chung; Elizabeth C Li; Selen Uman; Pavan Atluri; Jason A Burdick Journal: J Control Release Date: 2018-07-04 Impact factor: 9.776
Authors: Christopher B Rodell; Zhang L Zhang; Neville N Dusaj; Yousi Oquendo; Madonna E Lee; Wobbe Bouma; Joseph H Gorman; Jason A Burdick; Robert C Gorman Journal: Semin Thorac Cardiovasc Surg Date: 2019-11-02
Authors: David S Li; Reza Avazmohammadi; Christopher B Rodell; Edward W Hsu; Jason A Burdick; Joseph H Gorman; Robert C Gorman; Michael S Sacks Journal: Acta Biomater Date: 2020-07-30 Impact factor: 8.947
Authors: David S Li; Reza Avazmohammadi; Samer S Merchant; Tomonori Kawamura; Edward W Hsu; Joseph H Gorman; Robert C Gorman; Michael S Sacks Journal: J Mech Behav Biomed Mater Date: 2019-11-02